Ameritrust Corporation, announced a potential 10-year, Indefinite Delivery/Indefinite Quantity contract award with a ceiling value of $250 million from the Biomedical Advanced Research and Development Authority, a division of the Office of the Assistant Secretary for Preparedness and Response with the Department of Health and Human Services. This new contract complements ATCC's ongoing support of the government's COVID-19 pandemic response with BARDA, the National Institute of Allergy and Infectious Diseases, the Centers for Disease Control and Prevention, and the Food and Drug Administration. ATCC continues to fulfill its mission to bring standardization to biological material and investigational product management. In addition, this initiative provides new capabilities for the Clinical Studies Network that will enhance continuity across the BARDA portfolio. The BARDA initiative will build on lessons-learned from ATCC's existing contracts with the National Cancer Institute.